Francisco Epelde: Development and Validation of a Nomogram for Predicting Bleeding Risk in Patients with PE
Francisco Epelde, Attending Physician, internal Medicine Service at Parc Taulí University Hospital, posted on LinkedIn:
” ‘Development and Validation of a Nomogram for Predicting Bleeding Risk in Patients with Pulmonary Embolism’
DOI: 10.3389/fmed.2025.1692156
Authors: Tian Ye, Wanlin Lei, Maofeng Wang, Lili Xu
Read full article here or print here.
As Academic Editor, I had the privilege of overseeing this excellent study by Ye et al. (Wenzhou Medical University, China), which provides an important step toward personalized medicine in pulmonary embolism (PE) management.
Why this work matters:
Bleeding remains one of the most serious complications of anticoagulation therapy in PE. Current clinical scores—such as HAS-BLED or ATRIA—were not specifically developed for this population and often fail to capture the true hemorrhagic risk in acute PE settings.
This study overcomes that gap by developing and validating the first PE-specific bleeding risk nomogram, integrating six easily measurable clinical parameters: prior bleeding history, renal insufficiency, red blood cell count, systolic pressure, cerebral infarction, and creatinine.
Using data from 5,632 hospitalized patients, the model showed strong predictive performance (AUC 0.73–0.76) and was internally validated with excellent calibration. Importantly, decision curve analysis demonstrated clear clinical benefit—reducing major bleeding by up to 42% compared to standard care.
In essence, this paper exemplifies how data-driven tools can translate complex statistical modeling into bedside decision-making, supporting safer, more individualized anticoagulation strategies for patients with pulmonary embolism.”
Get insights from Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics